Carthamus Leaf
Carthamus Leaf contains hydroxysafflor yellow A (HSYA) and safflower polysaccharides (SPS) that inhibit platelet aggregation through PI3K/AKT pathway modulation and enhance immune cell cytotoxicity. These compounds demonstrate anti-inflammatory effects by suppressing IL-6, IL-1β, TNF-α, and COX-2 expression in laboratory studies.

Origin & History
Carthamus Leaf is derived from Carthamus tinctorius, commonly known as safflower, an annual plant native to the dry temperate plains of Central and West Asia, North Africa, and the Middle East. Its leaves are valued in functional nutrition for their circulatory, anti-inflammatory, and detoxifying properties, particularly supporting cardiovascular and liver health.
Historical & Cultural Context
In traditional Unani, Tibetan, and Chinese medicine, Carthamus Leaf has been revered for centuries as the "leaf of flowing blood." It was traditionally used to dispel stagnation, ease pain, support menstrual regulation, and cleanse the liver, symbolically linked to vitality and the restoration of inner rhythm.
Health Benefits
- **Enhances blood circulation**: and cardiovascular flow, supporting overall vascular health. - **Supports menstrual regulation**: and uterine health, promoting hormonal balance. - **Reduces systemic inflammation**: and swelling through its bioactive compounds. - **Aids liver cleansing**: and detoxification processes, supporting hepatic function. - **Provides respiratory relief**: through mild expectorant effects, easing congestion. - **Exhibits antioxidant activity,**: protecting cells from oxidative damage.
How It Works
Hydroxysafflor yellow A (HSYA) inhibits thrombosis by suppressing PI3K/AKT pathway, increasing BAD expression while decreasing Bcl-2, and enhancing GSH/GSSG balance with elevated SOD levels. Safflower polysaccharides (SPS) trigger G0/G1 cell cycle arrest, inhibit mTOR signaling, and enhance NK cell cytotoxicity while stimulating pro-inflammatory cytokines via NF-κB activation in lymphocytes and macrophages. These compounds collectively reduce inflammatory mediators IL-6, IL-1β, TNF-α, and matrix metalloproteinases MMP-2/9.
Scientific Research
Research, including in vitro and animal studies, supports Carthamus Leaf's traditional uses, highlighting its ability to promote blood circulation, reduce inflammation, and support liver detoxification. Studies indicate its potential for cardiovascular and uterine health benefits, primarily attributed to its flavonoid and phenolic acid content, though human clinical trials are ongoing.
Clinical Summary
Current evidence derives primarily from in vitro and animal studies, with no published human clinical trials providing quantified patient outcomes. Laboratory studies demonstrate SPS induced significant apoptosis in HN-6 cells (p<0.05) and inhibited tumor xenografts with measurable changes in Bcl-2/COX-2 reduction and increased Bax/cleaved caspase-3 expression. Animal studies show SPS reversed NK cell inhibition in T739 lung cancer mice and enhanced cytotoxic T lymphocyte activity. While traditional use spans cardiovascular disease and diabetes treatment from 1978-2025 without reported adverse events, controlled human trials with statistical endpoints are lacking.
Nutritional Profile
- Flavonoids: Including quercetin, kaempferol, and luteolin, offering antioxidant and anti-inflammatory benefits. - Phenolic Acids: Such as chlorogenic acid, contributing to antioxidant and metabolic support. - Saponins: Bioactive compounds that may support cardiovascular and detoxification pathways. - Trace Minerals: Including iron and potassium, essential for blood health and electrolyte balance.
Preparation & Dosage
- Forms: Traditionally used as dried leaves for decoctions and teas; modern applications include extracts in women's health formulas, liver detox blends, and anti-inflammatory infusions. - Preparation: Brew dried leaves into an infusion or decoction. - Dosage: Recommended intake is 1–2 grams per day of dried leaf infusion, or 300–600 mg per day of a standardized extract.
Synergy & Pairings
Role: Polyphenol/antioxidant base Intention: Cardio & Circulation | Detox & Liver | Hormonal Balance Primary Pairings: - Ginger (Zingiber officinale) - Dong Quai (Angelica sinensis) - Dandelion Root (Taraxacum officinale) - Red Sage (Salvia miltiorrhiza)
Safety & Interactions
No specific safety data, drug interactions, or contraindications are documented in available research literature. HSYA's platelet aggregation inhibition may theoretically interact with anticoagulant medications like warfarin or heparin, though this remains unconfirmed by clinical studies. Traditional clinical use for cardiovascular diseases and diabetes over several decades suggests general tolerability, but formal safety profiling is absent. Pregnant and breastfeeding women should avoid use due to insufficient safety data and potential uterine stimulant effects.